tiprankstipranks
Trending News
More News >
Bluejay Diagnostics (BJDX)
NASDAQ:BJDX
US Market

Bluejay Diagnostics (BJDX) Price & Analysis

Compare
110 Followers

BJDX Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.08%99.92%
Insiders
0.08%
Mutual Funds
― Other Institutional Investors
99.92% Public Companies and
Individual Investors

BJDX FAQ

What was Bluejay Diagnostics’s price range in the past 12 months?
Bluejay Diagnostics lowest stock price was $1.46 and its highest was $188.55 in the past 12 months.
    What is Bluejay Diagnostics’s market cap?
    Bluejay Diagnostics’s market cap is $2.48M.
      When is Bluejay Diagnostics’s upcoming earnings report date?
      Bluejay Diagnostics’s upcoming earnings report date is Apr 16, 2025 which is 63 days ago.
        How were Bluejay Diagnostics’s earnings last quarter?
        Bluejay Diagnostics released its earnings results on Nov 07, 2024. The company reported -$7.754 earnings per share for the quarter, missing the consensus estimate of N/A by -$7.754.
          Is Bluejay Diagnostics overvalued?
          According to Wall Street analysts Bluejay Diagnostics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Bluejay Diagnostics pay dividends?
            Bluejay Diagnostics does not currently pay dividends.
            What is Bluejay Diagnostics’s EPS estimate?
            Bluejay Diagnostics’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Bluejay Diagnostics have?
            Bluejay Diagnostics has 1,494,182 shares outstanding.
              What happened to Bluejay Diagnostics’s price movement after its last earnings report?
              Bluejay Diagnostics reported an EPS of -$7.754 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.15%.
                Which hedge fund is a major shareholder of Bluejay Diagnostics?
                Currently, no hedge funds are holding shares in BJDX

                Company Description

                Bluejay Diagnostics

                Bluejay Diagnostics, Inc. (BJDX) is a medical diagnostics company focused on developing and commercializing innovative point-of-care solutions for the healthcare industry. The company operates primarily within the biotechnology and healthcare sectors, leveraging advanced technology to enhance diagnostic testing. Its core product is the Symphony System, designed to provide rapid and accurate testing for critical care applications, allowing healthcare providers to make timely decisions and improve patient outcomes.
                Similar Stocks
                Company
                Price & Change
                Follow
                Helius Medical Technologies
                Catheter Precision
                INVO Fertility
                Tivic Health Systems
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis